TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07563309: A Study to Evaluate the Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test by Trained Personnel at Near-Patient and Point-of-Care Settings

Sponsor: bioLytical Laboratories · Phase: PHASE2 · Area: INFECTIOUS_VACCINE · Target Enrollment: 1000 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$9,408,000

Rescue Site Savings

+$6,203,400

Unlock Full NCT07563309 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07563309 Rescue Dossier →